Lipid Infusions to Optimize Nutrition Trial

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 30, 2028

Study Completion Date

December 31, 2030

Conditions
Bronchopulmonary DysplasiaNeurodevelopmental Impairment
Interventions
DRUG

SOLE

Participants will first receive LE at 1 g/kg/day, then will advance to 2 g/kg/day and lastly to 3 g/kg/day as tolerated to titrate based on triglyceride level \<250 mg/dL, per clinical team

DRUG

MOLE

Participants will first receive LE at 1 g/kg/day, then will advance to 2 g/kg/day and lastly to 3 g/kg/day as tolerated to titrate based on triglyceride level \<250 mg/dL, per clinical team

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER